Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
21642 | 411 | 41.8 | 84% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
275 | 3 | NSAIDS//CYCLOOXYGENASE//CYCLOOXYGENASE 2 | 43399 |
466 | 2 | NSAIDS//NON STEROIDAL ANTI INFLAMMATORY DRUGS//COX 2 INHIBITORS | 15930 |
21642 | 1 | GEORGE M OBRIEN KIDNEY UROL DIS//GEORGE OBRIEN KIDNEY UROL DIS//MACULA DENSA | 411 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | GEORGE M OBRIEN KIDNEY UROL DIS | address | 650560 | 4% | 49% | 18 |
2 | GEORGE OBRIEN KIDNEY UROL DIS | address | 371472 | 1% | 100% | 5 |
3 | MACULA DENSA | authKW | 326959 | 6% | 18% | 25 |
4 | POSTNATAL KIDNEY DEVELOPMENT | authKW | 167161 | 1% | 75% | 3 |
5 | PROSTAGLANDIN SYNTHASE G2 H 2 | authKW | 167161 | 1% | 75% | 3 |
6 | CISPLATIN INDUCED RENAL FAILURE | authKW | 99058 | 0% | 67% | 2 |
7 | VANDERBILT GEORGE M OBRIEN KIDNEY UROL DIS | address | 99058 | 0% | 67% | 2 |
8 | CYCLOOXYGENASE | authKW | 87597 | 16% | 2% | 64 |
9 | CYCLOOXYGENASE 2 COX 2 INHIBITORS | authKW | 79242 | 1% | 27% | 4 |
10 | PROSTAGLANDINS | authKW | 78794 | 22% | 1% | 89 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Urology & Nephrology | 7598 | 40% | 0% | 163 |
2 | Physiology | 2422 | 27% | 0% | 110 |
3 | Peripheral Vascular Diseases | 562 | 11% | 0% | 47 |
4 | Pharmacology & Pharmacy | 127 | 13% | 0% | 52 |
5 | Medicine, Research & Experimental | 46 | 5% | 0% | 21 |
6 | Pathology | 45 | 4% | 0% | 15 |
7 | Toxicology | 26 | 3% | 0% | 13 |
8 | Cell Biology | 21 | 6% | 0% | 24 |
9 | Transplantation | 10 | 1% | 0% | 6 |
10 | Rheumatology | 10 | 1% | 0% | 5 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | GEORGE M OBRIEN KIDNEY UROL DIS | 650560 | 4% | 49% | 18 |
2 | GEORGE OBRIEN KIDNEY UROL DIS | 371472 | 1% | 100% | 5 |
3 | VANDERBILT GEORGE M OBRIEN KIDNEY UROL DIS | 99058 | 0% | 67% | 2 |
4 | AGING REGENERAT CARECHILE UC | 74294 | 0% | 100% | 1 |
5 | BIOCHEM DPT | 74294 | 0% | 100% | 1 |
6 | BUSINESS UNIT TRANSPLANTAT IMMUNOL | 74294 | 0% | 100% | 1 |
7 | CARE UC | 74294 | 0% | 100% | 1 |
8 | CHEST DIS SURG DPT | 74294 | 0% | 100% | 1 |
9 | HYPERTENS KIDNEY DIABET VASC DIS | 74294 | 0% | 100% | 1 |
10 | INVEST BIOMED SALAMANCA IECSCYL IBSAL | 74294 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY | 49445 | 16% | 1% | 66 |
2 | KIDNEY INTERNATIONAL | 3714 | 7% | 0% | 27 |
3 | HYPERTENSION | 3402 | 6% | 0% | 23 |
4 | JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2603 | 4% | 0% | 16 |
5 | NEPHRON EXPERIMENTAL NEPHROLOGY | 2360 | 1% | 1% | 4 |
6 | CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION | 1676 | 1% | 0% | 6 |
7 | NEPHRON PHYSIOLOGY | 1666 | 0% | 1% | 2 |
8 | EXPERIMENTAL NEPHROLOGY | 1208 | 1% | 1% | 3 |
9 | CLINICAL AND EXPERIMENTAL NEPHROLOGY | 1137 | 1% | 0% | 4 |
10 | JOURNAL OF TOXICOLOGIC PATHOLOGY | 868 | 0% | 1% | 2 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | CHENG, HF , HARRIS, RC , (2005) RENAL EFFECTS OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS AND SELECTIVE CYCLOOXYGENASE-2 INHIBITORS.CURRENT PHARMACEUTICAL DESIGN. VOL. 11. ISSUE 14. P. 1795-1804 | 64 | 56% | 61 |
2 | HARRIS, RC , (2006) COX-2 AND THE KIDNEY.JOURNAL OF CARDIOVASCULAR PHARMACOLOGY. VOL. 47. ISSUE . P. S37-S42 | 46 | 68% | 45 |
3 | KRAMER, BK , KAMMERL, MC , KOMHOFF, M , (2004) RENAL CYCLOOXYGENASE-2 (COX-2) - PHYSIOLOGICAL, PATHOPHYSIOLOGICAL, AND CLINICAL IMPLICATIONS.KIDNEY & BLOOD PRESSURE RESEARCH. VOL. 27. ISSUE 1. P. 43-62 | 74 | 46% | 27 |
4 | HARRIS, RC , (2008) AN UPDATE ON CYCLOOXYGENASE-2 EXPRESSION AND METABOLITES IN THE KIDNEY.CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION. VOL. 17. ISSUE 1. P. 64-69 | 39 | 65% | 12 |
5 | GREEN, T , GONZALEZ, AA , MITCHELL, KD , NAVAR, LG , (2012) THE COMPLEX INTERPLAY BETWEEN CYCLOOXYGENASE-2 AND ANGIOTENSIN II IN REGULATING KIDNEY FUNCTION.CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION. VOL. 21. ISSUE 1. P. 7-14 | 36 | 61% | 11 |
6 | CHENG, HF , HARRIS, RC , (2004) CYCLOOXYGENASES, THE KIDNEY, AND HYPERTENSION.HYPERTENSION. VOL. 43. ISSUE 3. P. 525-530 | 37 | 65% | 81 |
7 | HARRIS, RC , BREYER, MD , (2006) UPDATE ON CYCLOOXYGENASE-2 INHIBITORS.CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. VOL. 1. ISSUE 2. P. 236 -245 | 52 | 45% | 41 |
8 | HARRIS, RC , ZHANG, MZ , CHENG, HF , (2004) CYCLOOXYGENASE-2 AND THE RENAL RENIN-ANGIOTENSIN SYSTEM.ACTA PHYSIOLOGICA SCANDINAVICA. VOL. 181. ISSUE 4. P. 543-547 | 29 | 81% | 55 |
9 | RIOS, A , VARGAS-ROBLES, H , GAMEZ-MENDEZ, AM , ESCALANTE, B , (2012) CYCLOOXYGENASE-2 AND KIDNEY FAILURE.PROSTAGLANDINS & OTHER LIPID MEDIATORS. VOL. 98. ISSUE 3-4. P. 86-90 | 26 | 74% | 14 |
10 | KOMERS, R , ANDERSON, S , EPSTEIN, M , (2001) RENAL AND CARDIOVASCULAR EFFECTS OF SELECTIVE CYCLOOXYGENASE-2 INHIBITORS.AMERICAN JOURNAL OF KIDNEY DISEASES. VOL. 38. ISSUE 6. P. 1145 -1157 | 37 | 62% | 44 |
Classes with closest relation at Level 1 |